Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2008-4-3
pubmed:abstractText
Aged canines (dogs) accumulate human-type beta-amyloid (Abeta) in diffuse plaques in the brain with parallel declines in cognitive function. We hypothesized that reducing Abeta in a therapeutic treatment study of aged dogs with preexisting Abeta pathology and cognitive deficits would lead to cognitive improvements. To test this hypothesis, we immunized aged beagles (8.4-12.4 years) with fibrillar Abeta(1-42) formulated with aluminum salt (Alum) for 2.4 years (25 vaccinations). Cognitive testing during this time revealed no improvement in measures of learning, spatial attention, or spatial memory. After extended treatment (22 vaccinations), we observed maintenance of prefrontal-dependent reversal learning ability. In the brain, levels of soluble and insoluble Abeta(1-40) and Abeta(1-42) and the extent of diffuse plaque accumulation was significantly decreased in several cortical regions, with preferential reductions in the prefrontal cortex, which is associated with a maintenance of cognition. However, the amount of soluble oligomers remained unchanged. The extent of prefrontal Abeta was correlated with frontal function and serum anti-Abeta antibody titers. Thus, reducing total Abeta may be of limited therapeutic benefit to recovery of cognitive decline in a higher mammalian model of human brain aging and disease. Immunizing animals before extensive Abeta deposition and cognitive decline to prevent oligomeric or fibrillar Abeta formation may have a greater impact on cognition and also more directly evaluate the role of Abeta on cognition in canines. Alternatively, clearing preexisting Abeta from the brain in a treatment study may be more efficacious for cognition if combined with a second intervention that restores neuron health.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
2
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3555-66
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18385314-Aging, pubmed-meshheading:18385314-Amyloid beta-Peptides, pubmed-meshheading:18385314-Analysis of Variance, pubmed-meshheading:18385314-Animals, pubmed-meshheading:18385314-Behavior, Animal, pubmed-meshheading:18385314-Brain, pubmed-meshheading:18385314-Choice Behavior, pubmed-meshheading:18385314-Cognition, pubmed-meshheading:18385314-Discrimination Learning, pubmed-meshheading:18385314-Dogs, pubmed-meshheading:18385314-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18385314-Female, pubmed-meshheading:18385314-Immunization, pubmed-meshheading:18385314-Immunization Schedule, pubmed-meshheading:18385314-Longitudinal Studies, pubmed-meshheading:18385314-Male, pubmed-meshheading:18385314-Memory, pubmed-meshheading:18385314-Neurofibrillary Tangles, pubmed-meshheading:18385314-Neuropsychological Tests, pubmed-meshheading:18385314-Peptide Fragments
pubmed:year
2008
pubmed:articleTitle
A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
pubmed:affiliation
Institute for Brain Aging and Dementia, and Department of Neurology, University of California, Irvine, Irvine, California 92697, USA. ehead@uci.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural